Allergan breast implants settlement
A number of claimants represented by Leigh Day in their claims regarding Allergan breast implants, have now settled their cases.
Posted on 15 April 2026
Allergan breast implants were removed from the market in 2018 after being linked to a rare form of breast cancer.
The following statement in relation to the case has been agreed:
“During the course of 2024/2025, Leigh Day provided legal representation to a number of individuals who developed the condition referred to as Breast Implant-Associated Anaplastic Large Cell Lymphoma, or BIA-ALCL. These matters have been resolved as between the parties. For the avoidance of doubt, no admission of liability was made by Allergan Limited, nor by any of its affiliates, in relation to these matters.”
Leigh Day is no longer pursuing product liability claims against Allergan Limited or any related corporate entity.
Sarah Moore
Leading environment and product safety lawyer
Those seriously injured or bereaved as a result of Covid-19 vaccine hope upcoming report will trigger long‑awaited reform of vaccine compensation scheme
A group of vaccine-injured and bereaved families say they are hopeful that the recommendations of the UK Covid-19 Inquiry due to be published on 16 April 2026 will finally pave the way for meaningful reform of the Vaccine Damage Payment Scheme (VDPS)
High levels of ‘forever chemicals’ PFAS found in some Bentham residents
Investigations by ITV and ENDS Report have revealed that a number of Bentham residents have high levels of ‘forever chemicals’, known as PFAS, in their blood.